Evidence map›Paper›PMID 30917485›Full record

ArticleMolecules (Basel, Switzerland)2019

Enhanced Liver Targeting of Camptothecin via Conjugation with Deoxycholic Acid.

Linxia Xiao, Endian Yu, Hanlin Yue, Qingyong Li

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Drug delivery · 2021
    Article
  7. Physiology and Physical Chemistry of Bile Acids.International journal of molecular sciences · 2021
    Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Linxia XiaoCollaborative Innovation Center of Yangtze River Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310014, China. xiaolinxiaxlx@126.com.
Endian YuCollege of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, China. yu19960216@126.com.
Hanlin YueCollege of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, China. yhl333666@126.com.
Qingyong LiCollaborative Innovation Center of Yangtze River Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310014, China. liqy@zjut.edu.cn.
Zhejiang University of Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Camptothecin (CPT) shows potent anticancer activity through inhibition of topoisomerase I. However, its water insolubility and severe toxicity limit its clinical application. Coupling with bile acid moieties is a promising method for liver-targeted drug delivery, which takes advantage of the bile acid receptors on hepatocytes. In this study, we evaluated the potential liver targeting and stability of a deoxycholic acid-CPT conjugate (

Indexed as

Administration, OralAnimalsAntineoplastic Agents, PhytogenicCamptothecinCell ProliferationDeoxycholic AcidDrug StabilityHep G2 CellsHumansLiverMiceModels, BiologicalRatsSolubilityTissue DistributionAntineoplastic Agents, PhytogenicCamptothecinDeoxycholic Acidantitumor activitybile acidbiodistributioncamptothecinliver targetinguptake

Identifiers

PMID30917485
PMCPMC6472190
OpenAlexW2925270452

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.